Latest filing published 14 Dec 2020 for Allergy Therapeutics Plc.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -32.4%Entry £0.17 · Close at T+365 £0.12
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Manuel Llobet: trading record in brief
All filings by Manuel Llobet on record concern Allergy Therapeutics PLC. Between 7 November 2017 and 8 December 2020, the trades on record add up to 3 filings.
No open-market sale appears; the market trades are 1 purchase worth €9,899. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 1 share grant.
The newest entry dates from 14 December 2020: a transaction, in Allergy Therapeutics PLC. The last insider purchase was made public on 24 October 2018, 2,937 days ago. Typically, a trade is published a median of 1 day after it takes place. Under the UK Market Abuse Regulation, managers have three business days to notify their trades. This summary is built from RNS (LSE) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Manuel Llobet
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,125,000 sharesLondon Stock Exchange - AIMISIN GB00B02LCQ05FCA-NSM:3814401
- 50,000 shares@ £0.175100.0% of flowLondon Stock Exchange - AIMISIN GB00B02LCQ05FCA-NSM:LSE20181024070003_13839884_20200330111442527_8083-0Canonical exit: 21 Jan 2019 (T+90)
- 626,399 shares@ €0.0001London Stock Exchange, AIMISIN GB00B02LCQ05FCA-NSM:LSE20171107115435_13423211_20200330131534208_5697
3 of 3 declarations